These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19408411)

  • 21. Proton pump inhibitors linked to fracture risk.
    Voelker R
    JAMA; 2010 Jul; 304(1):29. PubMed ID: 20606141
    [No Abstract]   [Full Text] [Related]  

  • 22. Addicted to acid suppression.
    Hanauer SB
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):497. PubMed ID: 19713979
    [No Abstract]   [Full Text] [Related]  

  • 23. The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine.
    Namazi MR
    Lupus; 2009 Feb; 18(2):104-5. PubMed ID: 19151110
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteoporosis caution: men at risk. Part I: causes and diagnosis.
    Harv Mens Health Watch; 2008 Nov; 13(4):1-4. PubMed ID: 19024768
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteoporosis: a growing problem.
    Johnston CC
    J S C Med Assoc; 2001 Mar; 97(3):122-3. PubMed ID: 11285885
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term therapy with proton pump inhibitors is associated with decreased bone density.
    Bratanic A; Kokic S; Hozo I; Barisic I; Kokic V
    Med Hypotheses; 2009 May; 72(5):608-9. PubMed ID: 19217215
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteoporosis and fragility fractures: identifying those at risk and raising public awareness.
    Tanna N
    Nurs Times; 2009 Sep 29-Oct 5; 105(38):28-31. PubMed ID: 19860068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors may trigger vitiligo by rendering melanocytes prone to apoptosis.
    Namazi MR
    Br J Dermatol; 2008 Apr; 158(4):844-5. PubMed ID: 18205862
    [No Abstract]   [Full Text] [Related]  

  • 29. A caution on Plavix and PPIs.
    Johns Hopkins Med Lett Health After 50; 2009 Jul; 21(5):3. PubMed ID: 19623737
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors that decrease the effectiveness of clopidogrel.
    Aschenbrenner DS
    Am J Nurs; 2009 Jun; 109(6):66-7. PubMed ID: 19478613
    [No Abstract]   [Full Text] [Related]  

  • 31. [Osteoporosis in patients during oral anticoagulant treatment].
    Wellhöfer B
    Dtsch Med Wochenschr; 2005 Dec; 130(48):2790; author reply 2790. PubMed ID: 16307414
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic diarrhea responding to proton pump inhibitors: a clinical sign of Zollinger-Ellison syndrome.
    Zimmer V; Schilling MK; Buecker A; Lammert F; Raedle J
    Am J Med; 2009 Nov; 122(11):e9-e10. PubMed ID: 19854317
    [No Abstract]   [Full Text] [Related]  

  • 33. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition].
    De Rocker H
    J Pharm Belg; 2009 Sep; (3):89-90. PubMed ID: 19873849
    [No Abstract]   [Full Text] [Related]  

  • 35. Are proton pump inhibitors really superior to famotidine in Japanese ulcer patients?
    Haruma K; Kamada T; Manabe N; Kusunoki H; Honda K; Inoue K; Shiotani A
    Hepatogastroenterology; 2009; 56(93):1059-63. PubMed ID: 19760941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When should stress ulcer prophylaxis be used in the ICU?
    Quenot JP; Thiery N; Barbar S
    Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected consequences of proton pump inhibitor use.
    Altman KW; Radosevich JA
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):564-6. PubMed ID: 19861191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPI inhibitors.
    Edson DH
    Conn Med; 2008; 72(6):375. PubMed ID: 18610717
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.
    Bhoopalam N; Campbell SC; Moritz T; Broderick WR; Iyer P; Arcenas AG; Van Veldhuizen PJ; Friedman N; Reda D; Warren S; Garewal H
    J Urol; 2009 Nov; 182(5):2257-64. PubMed ID: 19758618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responses to AFP journal club on hip fracture and PPI use.
    Millard PS
    Am Fam Physician; 2009 Jan; 79(2):83; author reply 83-4. PubMed ID: 19178057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.